经鼻间歇正压通气联合枸橼酸咖啡因治疗早产儿呼吸暂停疗效分析

付杰; 魏广友; 郑爱华; 刘军; 随素敏; 刘金广

doi:10.16766/j.cnki.issn.1674-4152.002946

经鼻间歇正压通气联合枸橼酸咖啡因治疗早产儿呼吸暂停疗效分析

doi: 10.16766/j.cnki.issn.1674-4152.002946

安徽医科大学附属亳州医院亳州市人民医院NICU，安徽亳州 236800

基金项目:

白求恩医学科学研究基金资助项目 SCE158NE

详细信息

通讯作者:
魏广友, E-mail: 13515682626@163.com

中图分类号: R722.6
计量
- 文章访问数: 265
- HTML全文浏览量: 152
- PDF下载量: 8
- 被引次数: 0
出版历程
- 收稿日期: 2022-04-21
- 网络出版日期: 2023-05-31

Effect of nasal intermittent positive pressure ventilation combined with caffeine citrate on apnea of prematurity

NICU, Bozhou People ' s Hospital of Anhui Medical University, Bozhou, Anhui 236800, China

摘要

摘要: 目的探讨经鼻间歇正压通气(NIPPV)联合枸橼酸咖啡因治疗早产儿呼吸暂停(AOP)的疗效及安全性，明确AOP的最佳治疗方案，提高临床救治水平。方法选取2019年10月—2021年7月亳州市人民医院NICU收治的96例AOP患儿，采用随机数字表法分为观察组(经鼻间歇正压通气+咖啡因)48例和对照组(经鼻持续气道正压通气+咖啡因)48例，比较2组患儿的疗效及不良反应发生率。结果观察组严重呼吸暂停发生率、拔管失败率及无创通气时间分别为6.3%(3/48)、8.3%(4/48)、(4.34±1.74)d，较对照组[20.8%(10/48)、22.9%(11/48)、(5.27±2.46)d]明显下降，差异有统计学意义(均P＜0.05)。观察组有创通气时间、吸氧时间、达全肠道喂养时间及住院时间分别为5.0(2.0，7.0)d、8.5(6.0，12.5)d、(14.92±5.61)d、18.0(14.3，28.0) d，与对照组[4.5(2.0，7.0)d、8.0(6.0，17.8)d、(16.67±5.96)d、17.5(15.0，23.8)d]比较差异均无统计学意义(均P＞0.05)。观察组患儿脑室内出血(IVH)、喂养不耐受、新生儿坏死性小肠结肠炎(NEC)、支气管肺发育不良(BPD)、早产儿视网膜病(ROP)、心动过速等不良反应发生率与对照组比较差异均无统计学意义(均P＞0.05)。结论 NIPPV联合枸橼酸咖啡因能够减少严重呼吸暂停发生率、拔管失败率及无创通气时间，且不增加不良反应的发生，是一种安全有效的AOP治疗方式。
- 经鼻间歇正压通气 /
- 枸橼酸咖啡因 /
- 早产儿呼吸暂停 /
- 疗效分析
Abstract: Objective To investigate the efficacy and safety of intermittent nasal positive pressure ventilation (NIPPV) combined with caffeine citrate in the treatment of premature apnea (AOP), and to clarify the best treatment plan of AOP, so as to improve the clinical treatment level. Methods A total of 96 children with AOP in NICU of Bozhou People ' s Hospital from October 2019 to July 2021 were selected and divided into observation group (48 cases, NIPPV+caffeine) and control group (48 cases, nasal continuous positive airway pressure + caffeine) by random number table method. The efficacy and incidence of adverse reactions of the two groups were compared. Results The incidence of severe apnea, extubation failure rate and non-invasive ventilation time in the observation group were 6.3% (3/48), 8.3% (4/48) and (4.34±1.74) days, respectively, which were significantly lower than those in the control group [20.8% (10/48), 22.9% (11/48) and (5.27±2.46) days], and the differences were statistically significant (all P < 0.05). The duration of invasive ventilation, oxygen inhalation time, the time to reach the whole intestinal feeding and the hospital stay in the observation group were 5.0(2.0, 7.0) days, 8.5(6.0, 12.5) days, (14.92±5.61) days, 18(14.3, 28.0) days, respectively, and there was no significant difference between the observation group and the control group [4.5(2.0, 7.0) days, 8.0(6.0, 17.8) days, (16.67±5.96) days, 17.5(15.0, 23.8) days], all P>0.05. There was no significant difference in the incidence of adverse reactions such as intraventricular hemorrhage (IVH), feeding intolerance, neonatal necrotizing enterocolitis (NEC), bronchopulmonary dysplasia (BPD), retinopathy of prematurity (ROP) and tachycardia between the two groups (all P>0.05). Conclusion NIPPV combined with caffeine citrate can reduce the incidence of severe apnea, extubation failure rate and non-invasive ventilation time without increasing the incidence of adverse reactions, which is a safe and effective treatment for AOP.
- Nasal intermittent positive pressure ventilation /
- Caffeine citrate /
- Apnea of prematurity /
- Curative effect analysis

HTML全文

表 1 2组早产儿一般情况比较

Table 1. Comparison of general conditions between two groups of premature infants

组别	例数	性别(例)		体重(x±s，g)	胎龄(x±s，周)	出生Apgar评分(x±s，分)
组别	例数	男	女	体重(x±s，g)	胎龄(x±s，周)	1 min	5 min
观察组	48	29	19	1 423.8±228.3	31.11±1.45	6.48±2.17	7.19±1.68
对照组	48	26	22	1 497.0±210.2	31.67±1.48	6.56±2.10	7.14±1.50
统计量		0.383^a		1.634^b	1.873^b	0.184^b	0.154^b
P值		0.536		0.102	0.064	0.849	0.898
注：^a为χ²值，^b为t值。

下载: 导出CSV

表 2 2组早产儿各项指标比较

Table 2. Comparison of various indicators between two groups of premature infants

组别	例数	有创通气时间[M(P₂₅,P₇₅)，d]	无创通气时间(x±s，d)	拔管失败[例(%)]	吸氧时间[M(P₂₅,P₇₅)，d]	严重呼吸暂停[例(%)]	达全肠道喂养时间(x±s，d)	住院时间(x±s，d)
观察组	48	5.0(2.0,7.0)	4.34±1.74	4(8.3)	8.5(6.0，12.5)	3(6.3)	14.92±5.61	18.0(14.3，28.0)
对照组	48	4.5(2.0，7.0)	5.27±2.46	11(22.9)	8.0(6.0，17.8)	10(20.8)	16.67±5.96	17.5(15.0，23.8)
统计量		0.004^a	2.138^b	3.872^c	0.224^a	4.198^c	1.481^b	0.246^a
P值		0.997	0.035	0.049	0.822	0.038	0.142	0.806
注：^a为Z值，^b为t值,^c为χ²值。

下载: 导出CSV

表 3 2组早产儿不良反应发生情况比较[例(%)]

Table 3. Comparison of the occurrence of adverse reactions between two groups of premature infants [cases(%)]

组别	例数	IVH	喂养不耐受	NEC	BPD	ROP	心动过速
研究组	48	12(25.0)	9(18.8)	4(8.3)	10(20.8)	5(10.4)	16(33.3)
对照组	48	14(29.2)	10(20.8)	5(10.4)	13(27.1)	7(14.6)	15(31.3)
χ²值		0.211	0.066	0.123	0.515	0.381	0.048
P值		0.646	0.798	0.726	0.473	0.537	0.827

下载: 导出CSV

参考文献(26)

[1]	张霄, 张海涛, 吕勇, 等. 不同维持剂量枸橼酸咖啡因治疗极低出生体重早产儿呼吸暂停的前瞻性随机对照研究[J]. 中国当代儿科杂志, 2019, 21(6): 558-561. https://www.cnki.com.cn/Article/CJFDTOTAL-DDKZ201906013.htm ZHANG X, ZHANG H T, LYU Y, et al. Clinical effect and safety of different maintenance doses of caffeine citrate in treatment of apnea in very low birth weight preterm infants: a prospective randomized controlled trial[J]. Chinese Journal of Contemporary Pediatrics, 2019, 21(6): 558-561. https://www.cnki.com.cn/Article/CJFDTOTAL-DDKZ201906013.htm
[2]	马娟, 汪丽, 李宛卫, 等. 枸橼酸咖啡因中剂量与小剂量治疗早产儿呼吸暂停的比较研究[J]. 儿科药学杂志, 2019, 25(10): 8-10. https://www.cnki.com.cn/Article/CJFDTOTAL-EKYX201910004.htm MA J, WANG L, LI Y W, et al. Comparison of Medium Dose and Low Dose of Caffeine Citrate in the Treatment of Apnea of Prematurity[J]. Journal of Pediatric Pharmacy, 2019, 25(10): 8-10. https://www.cnki.com.cn/Article/CJFDTOTAL-EKYX201910004.htm
[3]	梁文英, 黄水霞. 枸橼酸咖啡因联合俯卧位经鼻持续气道正压通气治疗早产儿频发呼吸暂停56例[J]. 安徽医药, 2020, 24(5): 1022-1026. https://www.cnki.com.cn/Article/CJFDTOTAL-AHYY202005046.htm LIANG W Y, HUANG S X. Clinical study of citrate caffeine combined with prone position nasal continuous positive airway pressure in the treatment of 56 premature infants with frequent apnea[J]. Anhui Medical and Pharmaceutical Journal, 2020, 24(5): 1022-1026. https://www.cnki.com.cn/Article/CJFDTOTAL-AHYY202005046.htm
[4]	VLIEGENTHART R, MIEDEMA M, HUTTEN G J, et al. High versus standard dose caffeine for apnoea: a systematic review[J]. Arch Dis Child Fetal Neonatal Ed, 2018, 103(6): F523-F529. doi: 10.1136/archdischild-2017-313556
[5]	相胜霞, 刘丹, 马雨萌, 等. 呼吸机持续气道正压通气联合枸橼酸咖啡因治疗早产儿呼吸暂停给药时间与临床疗效的关系[J]. 中国医学装备, 2021, 18(3): 117-120. https://www.cnki.com.cn/Article/CJFDTOTAL-YXZB202103028.htm XIANG S X, LIU D, MA Y M, et al. The combined treatment of ventilator NCPAP and citric acid caffeine for AOP the relationship between medication time and clinical efficacy[J]. China Medical Equipment, 2021, 18(3): 117-120. https://www.cnki.com.cn/Article/CJFDTOTAL-YXZB202103028.htm
[6]	ERICKSON G, DOBSON N R, HUNT C E. Immature control of breathing and apnea of prematurity: the known and unknown[J]. J Perinatol, 2021, 41(9): 2111-2123. doi: 10.1038/s41372-021-01010-z
[7]	涂秀英, 范娟, 王建辉. 不同剂量咖啡因治疗早产儿呼吸暂停的效果及对体重增长的影响[J]. 重庆医学, 2021, 50(10): 1676-1679. doi: 10.3969/j.issn.1671-8348.2021.10.012 TU X Y, FAN J, WANG J H. Effect of different doses of caffeine in treating apnea of prematurity and its impact on weight gain[J]. Chongqing medicine, 2021, 50(10): 1676-1679. doi: 10.3969/j.issn.1671-8348.2021.10.012
[8]	MA C, BROADBENT D, LEVIN G, et al. Discharging preterm infants home on caffeine, a single center experience[J]. Children (Basel), 2020, 7(9): 114. http://www.socolar.com/Article/Index?aid=100083906977&jid=100000038452
[9]	GILELES-HILLEL A, ERLICHMAN I, REITER J, et al. Apnea of prematurity- pathophysiology, treatment & prognosis[J]. Harefuah, 2020, 159(10): 754-758.
[10]	王华, 侯东敏. 晚期早产儿近/远期呼吸系统疾病研究进展[J]. 中华围产医学杂志, 2018, 21(12): 850-854. WANG H, HOU D M. Short-and long-term respiratory complications in late preterm infants: a review[J]. Chinese Journal of Perinatal Medicine, 2018, 21(12): 850-854.
[11]	王红霞, 徐心坦, 张晓慧. 不同时机应用经鼻持续气道正压通气联合肺表面活性物质治疗新生儿呼吸窘迫综合征的临床疗效观察[J]. 中国妇幼保健, 2017, 32(7): 1565-1568. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201707083.htm WANG H X, XU X D, ZHANG X H. Observation on the clinical effects of different starting time of nasal continuous positive airway pressure combined with pulmonary surfactant in treatment of neonatal respiratory distress syndrome[J]. Maternal and Child Health Care of China, 2017, 32(7): 1565-1568. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201707083.htm
[12]	唐珍, 钟灵毓. 枸橼酸咖啡因与氨茶碱用于早产儿呼吸暂停治疗的安全性和有效性研究[J]. 中国现代医学杂志, 2020, 30(17): 77-80. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXDY202017016.htm TANG Z, ZHONG L Y. Comparative study on the safety and effectiveness of caffeine citrate and aminophylline in the treatment of apnea in premature infants[J]. China Journal of Modern Medicine, 2020, 30(17): 77-80. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXDY202017016.htm
[13]	鲁志力, 杨超, 李志鑫, 等. 枸橼酸咖啡因治疗早产儿呼吸窘迫综合征的临床疗效及对神经发育的影响[J]. 中南医学科学杂志, 2020, 48(1): 42-44. https://www.cnki.com.cn/Article/CJFDTOTAL-HYYY202001012.htm LU Z L, YANG C, LI Z X, et al. Clinical efficacy of caffeine citrate in the treatment of respiratory distress syndrome in premature infants and its effect on neurodevelopment[J]. Medical Science Journal of Central South China, 2020, 48(1): 42-44. https://www.cnki.com.cn/Article/CJFDTOTAL-HYYY202001012.htm
[14]	MVRNER-LAVANCHY I M, DOYLE L W, SCHMIDT B, et al. Neurobehavioral outcomes 11 years after neonatal caffeine therapy for apnea of prematurity[J]. Pediatrics, 2018, 141(5): e20174047. DOI: 10.1542/peds.2017-4047.
[15]	张磊, 孙岩, 孙建伟, 等. 枸橼酸咖啡因注射液与氨茶碱注射液治疗低体重呼吸暂停早产儿的临床研究[J]. 中国临床药理学杂志, 2021, 37(7): 816-819. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ202107007.htm ZHANG L, SUN Y, SUN J W, et al. Clinical trial of caffeine citrate injection and aminophylline injection in the treatment of premature infants with low weight apnea[J]. The Chinese Journal of Clinical Pharmacology, 2021, 37(7): 816-819. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ202107007.htm
[16]	SYNNES A, GRUNAU R E. Neurodevelopmental outcomes after neonatal caffeine therapy[J]. Semin Fetal Neonatal Med, 2020, 25(6): 101160. DOI: 10.1016/j.siny.2020.101160.
[17]	杨泽凯, 刘西洋, 姜岑. 氨茶碱与枸橼酸咖啡因治疗对呼吸暂停新生儿神经行为和后期神经发育的影响[J]. 临床和实验医学杂志, 2019, 18(11): 1199-1202. https://www.cnki.com.cn/Article/CJFDTOTAL-SYLC201911023.htm YANG Z K, LIU X Y, JIANG C. Effects of different regimens on neurobehavior and late neurodevelopment in apnea newborn[J]. Journal of Clinical and Experimental Medicine, 2019, 18(11): 1199-1202. https://www.cnki.com.cn/Article/CJFDTOTAL-SYLC201911023.htm
[18]	胡婧, 程雁. 枸橼酸咖啡因联合机械通气治疗新生儿呼吸窘迫综合征的疗效[J]. 中国现代医学杂志, 2019, 29(7): 108-112. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXDY201907021.htm HU J, CHENG Y. Efficacy of Caffeine citrate combined with mechanical ventilation therapy in neonatal respiratory distress syndrome[J]. China Journal of Modern Medicine, 2019, 29(7): 108-112. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXDY201907021.htm
[19]	陈思钧, 庄泽吟, 陈淑特. 枸橼酸咖啡因联合经鼻持续气道正压通气治疗早产儿呼吸窘迫综合征的临床疗效[J]. 中国药物经济学, 2019, 14(6): 90-92. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYWA201906022.htm CHEN S J, ZHUANG Z Y, CHEN S T. Clinical Efficacy of Caffeine Citrate Combined with Nasal Continuous Positive Airway Pressure Ventilation in the Treatment of Respiratory Distress Syndrome in Premature Infants[J]. China Journal of Pharmaceutical Economics, 2019, 14(6): 90-92. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYWA201906022.htm
[20]	要丽君, 范雪爱. 无创呼吸支持下枸橼酸咖啡因与氨茶碱治疗早产儿呼吸暂停的疗效及收益比较[J]. 国际呼吸杂志, 2017, 37(21): 1633-1637. YAO L J, FAN X A. Comparison of the curative effect and benefits of caffeine citrate and aminophylline in treatment of apnea ofprematurity under noninvasive respiratory support[J]. International Journal of Respiration, 2017, 37(21): 1633-1637.
[21]	宋飞飞, 张兰. LISA技术和INSURE技术治疗早产儿呼吸窘迫综合征的疗效分析[J]. 中华全科医学, 2021, 19(8): 1322-1325, 1429. doi: 10.16766/j.cnki.issn.1674-4152.002051 SONG F F, ZHANG L. Comparison of LISA technique and INSURE technique in the treatment of respiratory distress syndrome in premature infants[J]. Chinese Journal of General Practice, 2021, 19(8): 1322-1325, 1429. doi: 10.16766/j.cnki.issn.1674-4152.002051
[22]	陈云, 陈信. 微创肺表面活性物质运用技术治疗早产儿呼吸窘迫综合征疗效观察[J]. 中华全科医学, 2020, 18(3): 355-357, 391. doi: 10.16766/j.cnki.issn.1674-4152.001245 CHEN Y, CHEN X. Observation on the effect of minimally invasive surfactant therapy in the treatment of premature infants with respiratory distress syndrome[J]. Chinese Journal of General Practice, 2020, 18(3): 355-357, 391. doi: 10.16766/j.cnki.issn.1674-4152.001245
[23]	EICHENWALD E C. Apnea of prematurity[J]. Pediatrics, 2016, 137(1). DOI: 10.1542/peds.2015-3757.
[24]	韦彦成. 枸橼酸咖啡因在早产儿呼吸暂停中的临床应用及对肺功能改善作用研究[J]. 临床肺科杂志, 2020, 25(6): 873-877. https://www.cnki.com.cn/Article/CJFDTOTAL-LCFK202006016.htm WEI Y C. Clinical application of caffeine citrate in apnea of premature infants and its effect on improving pulmonary function[J]. Journal of Clinical Pulmonary Medicine, 2020, 25(6): 873-877. https://www.cnki.com.cn/Article/CJFDTOTAL-LCFK202006016.htm
[25]	朱志成, 周建国, 陈超. 新生儿经鼻间歇正压通气的研究进展[J]. 中国当代儿科杂志, 2017, 19(12): 1301-1305. https://www.cnki.com.cn/Article/CJFDTOTAL-DDKZ201712016.htm ZHU Z C, ZHOU J G, CHEN C. Research advances in neonatal nasal intermittent positive pressure ventilation[J]. Chinese Journal of Contemporary Pediatrics, 2017, 19(12): 1301-1305. https://www.cnki.com.cn/Article/CJFDTOTAL-DDKZ201712016.htm
[26]	SABSABI B, HARRISON A, BANFIELD L, et al. Nasal intermittent positive pressure ventilation versus continuous positive airway pressure and apnea of prematurity: a systematic review and meta-analysis[J]. Am J Perinatol, 2021. DOI: 10.1055/s-0040-1722337.